P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro

AUTOR(ES)

Mancebo, Helena S.Y.

FONTE

Cold Spring Harbor Laboratory Press

RESUMO

To identify novel inhibitors of transcriptional activation by the HIV Tat protein, we used a combination of in vitro and in vivo Tat-dependent transcription assays to screen >100,000 compounds. All compounds identified blocked Tat-dependent stimulation of transcriptional elongation. Analysis of a panel of structurally diverse inhibitors indicated that their target is the human homolog of Drosophila positive transcription elongation factor b (P-TEFb). Loss of Tat transactivation in extracts depleted of the kinase subunit of human P-TEFb, PITALRE, was reversed by addition of partially purified human P-TEFb. Transfection experiments with wild-type or kinase knockout PITALRE demonstrated that P-TEFb is required for Tat function. Our results suggest that P-TEFb represents an attractive target for the development of novel HIV therapeutics.

Documentos Relacionados

• Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro
• P-TEFb kinase recruitment and function at heat shock loci
• Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription
• A model of repression: CTD analogs and PIE-1 inhibit transcriptional elongation by P-TEFb
• Identification of multiple cyclin subunits of human P-TEFb